1 |
Wen ZQ, Liu D, Zhang Y, Cai ZJ, Xiao WF, Li YS. G Protein-Coupled Receptors in Osteoarthritis: A Novel Perspective on Pathogenesis and Treatment. Front Cell Dev Biol 2021;9:758220. [PMID: 34746150 DOI: 10.3389/fcell.2021.758220] [Reference Citation Analysis]
|
2 |
Jayakar S, Shim J, Jo S, Bean BP, Singeç I, Woolf CJ. Developing nociceptor-selective treatments for acute and chronic pain. Sci Transl Med 2021;13:eabj9837. [PMID: 34757806 DOI: 10.1126/scitranslmed.abj9837] [Reference Citation Analysis]
|
3 |
Elwing JE, Atassi H, Rogers BD, Sayuk GS. Emerging therapies in the management of Irritable Bowel Syndrome (IBS). Expert Opin Emerg Drugs 2022. [PMID: 35266839 DOI: 10.1080/14728214.2022.2052043] [Reference Citation Analysis]
|
4 |
Li J, Remington JM, Liao C, Parsons RL, Schneebeli S, Braas KM, May V, Brewer M. GPCR Intracellular Loop Regulation of Beta-Arrestin-Mediated Endosomal Signaling Dynamics. J Mol Neurosci 2022. [PMID: 35538393 DOI: 10.1007/s12031-022-02016-8] [Reference Citation Analysis]
|
5 |
Camilleri M. Towards a new era with safer µ-opiate receptor analgesia. Gut 2022;71:1-2. [PMID: 33875448 DOI: 10.1136/gutjnl-2021-324618] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Decraecker L, Boeckxstaens G, Denadai-souza A. Inhibition of Serine Proteases as a Novel Therapeutic Strategy for Abdominal Pain in IBS. Front Physiol 2022;13:880422. [DOI: 10.3389/fphys.2022.880422] [Reference Citation Analysis]
|
7 |
Camilleri M. New Drugs on the Horizon for Functional and Motility Gastrointestinal Disorders. Gastroenterology 2021;161:761-4. [PMID: 33989661 DOI: 10.1053/j.gastro.2021.04.079] [Reference Citation Analysis]
|